-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Maintains Buy on PTC Therapeutics, Raises Price Target to $95

Benzinga·10/30/2026 20:07:35
語音播報
TD Cowen analyst Joseph Thome maintains PTC Therapeutics (NASDAQ:PTCT) with a Buy and raises the price target from $90 to $95.